Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Public ClinicalTrials.gov record NCT02072486. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Granzyme B Production as a Biomarker for the Immunomodulatory Activity of Sorafenib in HCC
Study identification
- NCT ID
- NCT02072486
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Roswell Park Cancer Institute
- Other
- Enrollment
- 30 participants
Conditions and interventions
Conditions
- Advanced Adult Hepatocellular Carcinoma
- Localized Non-Resectable Adult Hepatocellular Carcinoma
- Stage III Childhood Hepatocellular Carcinoma
- Stage IIIA Hepatocellular Carcinoma
- Stage IIIB Hepatocellular Carcinoma
- Stage IIIC Hepatocellular Carcinoma
- Stage IV Childhood Hepatocellular Carcinoma
- Stage IVA Hepatocellular Carcinoma
- Stage IVB Hepatocellular Carcinoma
Interventions
- Laboratory Biomarker Analysis Other
- Sorafenib Tosylate Drug
Other · Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2013
- Primary completion
- Jul 18, 2019
- Completion
- Jul 18, 2020
- Last update posted
- Jul 24, 2022
2013 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02072486, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 24, 2022 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02072486 live on ClinicalTrials.gov.